173026-23-8 Usage
Description
1-(2-Bromophenyl)-1-methylethylamine, also known as alpha-bromo-4-methylbenzylamine, is a chemical compound with the formula C9H12BrN. It is a colorless to pale yellow liquid with a faint amine odor. 1-(2-Bromophenyl)-1-methylethylamine is recognized for its structural properties that make it a versatile intermediate in various chemical syntheses.
Uses
Used in Pharmaceutical Industry:
1-(2-Bromophenyl)-1-methylethylamine is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(2-Bromophenyl)-1-methylethylamine serves as an intermediate in the production of agrochemicals. Its role in this industry is crucial for the synthesis of compounds that help improve crop protection and yield.
Used in Organic Synthesis:
Due to its structural properties, 1-(2-Bromophenyl)-1-methylethylamine is also used in organic synthesis for creating a range of organic compounds. Its versatility in this field is valuable for the development of new chemical entities with potential applications in various industries.
Safety and Handling:
Check Digit Verification of cas no
The CAS Registry Mumber 173026-23-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,3,0,2 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 173026-23:
(8*1)+(7*7)+(6*3)+(5*0)+(4*2)+(3*6)+(2*2)+(1*3)=108
108 % 10 = 8
So 173026-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BrN/c1-9(2,11)7-5-3-4-6-8(7)10/h3-6H,11H2,1-2H3
173026-23-8Relevant articles and documents
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Page/Page column 984-985, (2021/02/10)
The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
-
Paragraph 4472; 4473, (2016/05/02)
The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
Compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
-
, (2008/06/13)
The invention concerns novel benzisoselen-azoline and -azine derivatives. These novel derivatives have the following general formula (II): STR1 where: R1 to R8 and R10 have various meanings, in particular H, alkyl, etc . .
